Literature DB >> 7049137

Lidocaine in the treatment of tinnitus aurium. A double-blind study.

J M Israel, J S Connelly, S T McTigue, R E Brummett, J Brown.   

Abstract

Available reports suggest that lidocaine is capable of relieving symptoms of tinnitus, but no convincing data support this conclusion. By use of a placebo-controlled double-blind crossover study we found that 19 out of 26 patients with subjective tinnitus reported that their tinnitus was temporarily better or gone with intravenous (IV) lidocaine and that there was no change with IV saline.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7049137     DOI: 10.1001/archotol.1982.00790560009003

Source DB:  PubMed          Journal:  Arch Otolaryngol        ISSN: 0003-9977


  5 in total

Review 1.  Tinnitus.

Authors:  A Sismanis
Journal:  Curr Neurol Neurosci Rep       Date:  2001-09       Impact factor: 5.081

Review 2.  Drugs affecting the inner ear. A review of their clinical efficacy, mechanisms of action, toxicity, and place in therapy.

Authors:  C H Norris
Journal:  Drugs       Date:  1988-12       Impact factor: 9.546

Review 3.  Chronic tinnitus: an interdisciplinary challenge.

Authors:  Peter M Kreuzer; Veronika Vielsmeier; Berthold Langguth
Journal:  Dtsch Arztebl Int       Date:  2013-04-19       Impact factor: 5.594

4.  The value of tocainide in the treatment of tinnitus. A double-blind controlled study.

Authors:  J H Hulshof; P Vermeij
Journal:  Arch Otorhinolaryngol       Date:  1985

Review 5.  Multidisciplinary Tinnitus Research: Challenges and Future Directions From the Perspective of Early Stage Researchers.

Authors:  Jorge Piano Simoes; Elza Daoud; Maryam Shabbir; Sana Amanat; Kelly Assouly; Roshni Biswas; Chiara Casolani; Albi Dode; Falco Enzler; Laure Jacquemin; Mie Joergensen; Tori Kok; Nuwan Liyanage; Matheus Lourenco; Punitkumar Makani; Muntazir Mehdi; Anissa L Ramadhani; Constanze Riha; Jose Lopez Santacruz; Axel Schiller; Stefan Schoisswohl; Natalia Trpchevska; Eleni Genitsaridi
Journal:  Front Aging Neurosci       Date:  2021-06-11       Impact factor: 5.750

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.